Otte patienter (2%) behandlet med tenofovirdisoproxil 245 mg (som fumarat) udviklede K65R mutationen inden for de første 48 uger.
Eight (2%) tenofovir disoproxil 245 mg (as fumarate) treated patients developed the K65R mutation within the first 48 weeks.